Literature DB >> 28856930

Sepsis after uterine artery embolization-assisted termination of pregnancy with complete placenta previa: A case report.

Yinfeng Wang1, Xiufeng Huang1.   

Abstract

Uterine artery embolization (UAE)-assisted induction of labor is an alternative method of managing pregnant women with complete placenta previa (CPP). Sepsis secondary to UAE, although rare, is a serious complication. We herein present a case of severe sepsis following UAE-assisted termination of a pregnancy at 27 gestational weeks in a woman with CPP. The woman developed a high-grade fever and elevated inflammatory indices following UAE. She did not recover until the infected tissue was removed by emergency cesarean section. This case suggests that the increasing use of UAE for termination of pregnancy in women with CPP requires awareness regarding the possibility of serious sepsis associated with this procedure.

Entities:  

Keywords:  Uterine artery embolization; cesarean section; complete placenta previa; obstetric hemorrhage; sepsis; termination of pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28856930      PMCID: PMC6011329          DOI: 10.1177/0300060517723257

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


Introduction

Complete placenta previa (CPP), defined as complete coverage of the internal cervical os by the placenta, is a high-risk factor for obstetric hemorrhage. If the fetus is likely to survive, cesarean section or prophylactic uterine artery embolization (UAE) immediately followed by cesarean section is the first-choice technique for termination of pregnancy with CPP. In cases involving fetal demise or major malformation, which are not uncommon in pregnancy with CPP, cesarean section cannot decrease the intraoperative hemorrhage.[1,2] Moreover, delivery by cesarean section increases the risk of placental abnormalities, such as placenta accreta and cesarean scar pregnancy, in subsequent pregnancies. Termination of pregnancy in such conditions contributes to therapeutic dilemmas for the treating obstetricians. UAE blocks the main placental blood supply, thereby reducing the incidence of peripartum hemorrhage and avoiding cesarean section in women at risk. In two separate case series, Peng and Zhang[3] and Huang et al.[4] recommended UAE-assisted induction of labor as a safe method of managing women with CPP because it was associated with a lower incidence of postpartum hemorrhage and fewer complications (such as gluteal muscle pain) without any increase in the duration of labor. Our experience with the successful use of UAE in 16 women supports this recommendation. However, increased application of UAE-assisted induction of labor should be accompanied by an awareness of the serious complications associated with this procedure. We herein present a case of serious sepsis in a woman with CPP following UAE-assisted induction of labor that required emergency cesarean section.

Case report

The patient was a 31-year-old woman who was admitted at 27 weeks of gestation for abnormal fetal development identified on a routine prenatal checkup. Ultrasonography revealed anencephaly with a biparietal diameter of 5.4 cm and femur length of 2.8 cm. The fetal position was right sacrum anterior. The placenta was mostly located on the anterior uterine wall and completely covered the cervical os. Placenta accreta was ruled out on both ultrasonography and magnetic resonance imaging (Figure 1). At admission, her temperature was 37.1℃, and laboratory tests revealed a white blood cell (WBC) count of 13.0 × 109 cells/L with 81.4% neutrophils and a C-reactive protein (CRP) level of 1.8 mg/L. Her coagulation profile and liver and renal function tests results were normal.
Figure 1.

Imaging findings. (a) Diffusion-weighted imaging and (b) T2-weighted magnetic resonance imaging scans showed that the cervical os (white arrow) was completely covered by the placenta (black arrow). Axial scan.

Imaging findings. (a) Diffusion-weighted imaging and (b) T2-weighted magnetic resonance imaging scans showed that the cervical os (white arrow) was completely covered by the placenta (black arrow). Axial scan. On the second day following admission, 100 mg of ethacridine lactate was injected into the amniotic cavity to induce labor. Two hours later, UAE was performed by the Seldinger technique (Figure 2). Four hours following UAE, the patient was found to have a temperature of 41.1℃. Laboratory tests revealed a WBC count of 3.9 × 109 cells/L with 69.2% neutrophils and a CRP level of 28.2 mg/L. She was administered intravenous moxifloxacin at 0.4 g once daily. Her inflammatory marker levels were higher when tested 10 hours following UAE (WBC count, 21.5 × 109 cells/L with 98.1% neutrophils; CRP, 30.8 mg/L; procalcitonin, 48.34 ng/mL; activated partial thromboplastin time, 67.2 s; prothrombin time, 19.8 s; alanine transaminase, 142 U/L; and aspartate transaminase, 251 U/L). Her blood pressure decreased to 75/40 mmHg. She exhibited no evidence of uterine contraction or cervix dilatation. Septic shock was suspected, and an emergency cesarean section was performed to remove the infected tissues. The weight of the fetus was 400 g. Intravenous moxifloxacin (0.4 g once daily) and vancomycin (0.5 g twice daily) were administered for 1 week postoperatively. Both uterine cavity culture and blood cultures revealed Serratia marcescens sensitive to moxifloxacin. The patient was discharged on postoperative day 9, after her temperature and inflammatory markers had normalized.
Figure 2.

Uterine artery embolization was performed under local anesthesia along with two experienced interventional radiologists. The uterine artery (black arrow) was selectively catheterized with a 5-Fr Yashiro catheter (Terumo Corporation, Tokyo, Japan). Both uterine arteries were blocked with an absorbable gelatin sponge (Gelfoam; Pfizer, New York, NY, USA) measuring 1400 to 2000 µm at a total dose of 90 to 150 mg. L: left side. (a) Before embolization. (b) After embolization.

Uterine artery embolization was performed under local anesthesia along with two experienced interventional radiologists. The uterine artery (black arrow) was selectively catheterized with a 5-Fr Yashiro catheter (Terumo Corporation, Tokyo, Japan). Both uterine arteries were blocked with an absorbable gelatin sponge (Gelfoam; Pfizer, New York, NY, USA) measuring 1400 to 2000 µm at a total dose of 90 to 150 mg. L: left side. (a) Before embolization. (b) After embolization. The present study was approved by the ethics committee of Zhejiang University, and the termination of the pregnancy because of anencephaly was performed according to the Chinese law. The patient provided written informed consent for publication of her information and images.

Discussion

UAE is a safe technique for the control of certain hemorrhagic conditions in gynecology and obstetrics, such as postpartum hemorrhage, cesarean scar pregnancy, and arteriovenous malformations, and it is associated with a low complication rate.[5] The uteroplacental blood supply is an important factor contributing to intrapartum and postpartum hemorrhage.[6] CPP often leads to massive hemorrhage requiring urgent cesarean section and sometimes even hysterectomy. UAE-assisted induction of labor was recently described as a feasible method for termination of pregnancy in women with CPP and was reported to have a high rate of successful vaginal delivery.[3,4] The experience at our center is similar; among 20 women treated with UAE, 16 women (80%) had a successful vaginal delivery (unpublished data). UAE-associated infective complications result in a significantly high readmission rate and may occur despite the use of periprocedural prophylactic antibiotics. Although sepsis after UAE is very rare, it is potentially fatal. Sepsis has an overall incidence of 0.002% to 0.01% of all deliveries and is a leading cause of maternal mortality in the United States.[7] The patient in the present case had no evidence of infection before induction of labor, but uterine cavity and blood cultures isolated S. marcescens. The sepsis broke out shortly following UAE, and broad-spectrum antibiotics were ineffective until the infected tissues were removed following cesarean section. Although the underlying mechanism for sepsis in such cases is uncertain, the following factors may be involved: Downregulation of cell-mediated immunity during pregnancy may predispose women to certain infections,[8] a reduced blood supply following UAE may prevent antibiotic access to the uterus while uterine ischemia encourages bacterial proliferation,[9] and the closed uterine cavity secondary to the presence of CPP prevents drainage of inflammatory material or septic foci.[7] The involvement of these factors is supported by the prompt clinical improvement after emergency cesarean section and intravenous antibiotics. In conclusion, UAE effectively reduces the uteroplacental blood supply and the risk of hemorrhage in women at risk. However, UAE renders the uterus ischemic, which in combination with the sealed status of the uterus may encourage bacterial growth and result in sepsis. In these women, severe sepsis may be caused by multiple factors, especially uterine infections similar to chorioamnionitis. Our study suggests the need for obstetricians to be aware of the potential for serious sepsis following UAE-assisted termination of pregnancy in women with CPP.
  9 in total

1.  Persistence of placenta previa according to gestational age at ultrasound detection.

Authors:  Jodi S Dashe; Donald D McIntire; Ronald M Ramus; Rigoberto Santos-Ramos; Diane M Twickler
Journal:  Obstet Gynecol       Date:  2002-05       Impact factor: 7.661

Review 2.  Maternal Sepsis and Septic Shock.

Authors:  Ahmad Chebbo; Susanna Tan; Christelle Kassis; Leslie Tamura; Richard W Carlson
Journal:  Crit Care Clin       Date:  2015-10-19       Impact factor: 3.598

3.  Uterine artery embolization, not cesarean section, as an option for termination of pregnancy in placenta previa.

Authors:  Lingling Huang; Reenu Awale; Hui Tang; ZhiShan Zeng; FuRong Li; Yue Chen
Journal:  Taiwan J Obstet Gynecol       Date:  2015-04       Impact factor: 1.705

4.  Management of fetal death after 20 weeks of gestation complicated by placenta previa.

Authors:  J Marinus van der Ploeg; Joke M Schutte; Marie-Jose Pelinck; Anjoke J M Huisjes; Jos van Roosmalen; Johanna I P de Vries
Journal:  J Matern Fetal Neonatal Med       Date:  2007-03

5.  Decrease of uteroplacental blood flow after feticide during second-trimester pregnancy termination with complete placenta previa: quantitative analysis using contrast-enhanced ultrasound imaging.

Authors:  H Poret-Bazin; E G Simon; A Bleuzen; P A Dujardin; F Patat; F Perrotin
Journal:  Placenta       Date:  2013-08-24       Impact factor: 3.481

6.  Uterine sepsis with uterine artery embolisation in the management of obstetric bleeding.

Authors:  A Nakash; S Tuck; N Davies
Journal:  J Obstet Gynaecol       Date:  2012-01       Impact factor: 1.246

7.  Uterine arterial embolization to assist induction of labor among patients with complete placenta previa.

Authors:  Qiaozhen Peng; Weishe Zhang
Journal:  Int J Gynaecol Obstet       Date:  2015-04-30       Impact factor: 3.561

Review 8.  Uterine artery embolization: the role in obstetrics and gynecology.

Authors:  S Z Badawy; A Etman; M Singh; K Murphy; T Mayelli; M Philadelphia
Journal:  Clin Imaging       Date:  2001 Jul-Aug       Impact factor: 1.605

Review 9.  Severe sepsis and septic shock in pregnancy.

Authors:  John R Barton; Baha M Sibai
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

  9 in total
  8 in total

1.  Assessment of uterine artery geometry and hemodynamics in human pregnancy with 4d flow mri and its correlation with doppler ultrasound.

Authors:  Eileen Hwuang; Marta Vidorreta; Nadav Schwartz; Brianna F Moon; Kirpal Kochar; Matthew Dylan Tisdall; John A Detre; Walter R T Witschey
Journal:  J Magn Reson Imaging       Date:  2018-11-03       Impact factor: 4.813

2.  Application of laparoscopic internal iliac artery temporary occlusion and uterine repair combined with hysteroscopic aspiration in type III cesarean scar pregnancy.

Authors:  Xianghui Su; Miner Yang; Zhao Na; Canliang Wen; Meiling Liu; Chunfang Cai; Zhuohui Zhong; Bingqian Zhou; Xiang Tang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

3.  Evaluation of the treatment of high intensity focused ultrasound combined with suction curettage for exogenous cesarean scar pregnancy.

Authors:  Lin Mu; Huifang Weng; Xiaoyun Wang
Journal:  Arch Gynecol Obstet       Date:  2022-03-18       Impact factor: 2.493

4.  Combined laparoscopic and hysteroscopic management of cesarean scar pregnancy with temporary occlusion of bilateral internal iliac arteries: A case report and literature review.

Authors:  Jianqiong Li; Xia Li; Hailan Yu; Xiao Zhang; Wenzhi Xu; Jianhua Yang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

5.  Prophylactic uterine artery embolization in second-trimester pregnancy termination with complete placenta previa.

Authors:  Yinfeng Wang; Changchang Hu; Ningpin Pan; Chaolu Chen; Ruijin Wu
Journal:  J Int Med Res       Date:  2018-10-14       Impact factor: 1.671

6.  Laparoscopic combined hysteroscopic management of cesarean scar pregnancy with temporary occlusion of bilateral internal iliac arteries: A retrospective cohort study.

Authors:  Wenzhi Xu; Miao Wang; Jianqiong Li; Xiaona Lin; Weili Wu; Jianhua Yang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Rapid diagnosis and comprehensive bacteria profiling of sepsis based on cell-free DNA.

Authors:  Pei Chen; Shuo Li; Wenyuan Li; Jie Ren; Fengzhu Sun; Rui Liu; Xianghong Jasmine Zhou
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

8.  Using a cervical ripening balloon to penetrate the placenta and quickly reduce bleeding by pressing against the placenta during pregnancy termination for patients with placenta previa in the second trimester: Two cases report.

Authors:  Chang Su; Danqing Chen
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.